Article
New Orleans - New staging criteria for melanoma can help quantify a particular patient's prognosis, but results of a recent investigation emphasize that the risk estimates it provides are population-specific, DuPont Guerry, M.D. reported here at the annual meeting of the American Society of Clinical Oncology.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.